Larry Biegelsen
Stock Analyst at Wells Fargo
(4.20)
# 444
Out of 4,754 analysts
299
Total ratings
59.29%
Success rate
10.59%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Equal-Weight | $40 → $35 | $28.36 | +23.41% | 10 | Feb 26, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $120 → $117 | $102.04 | +14.66% | 8 | Feb 26, 2025 | |
| PEN Penumbra | Maintains: Overweight | $275 → $305 | $285.44 | +6.85% | 17 | Feb 19, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $96 → $103 | $87.35 | +17.92% | 3 | Feb 14, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $198 → $195 | $185.59 | +5.07% | 11 | Feb 11, 2025 | |
| BSX Boston Scientific | Maintains: Overweight | $100 → $118 | $103.79 | +13.69% | 13 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $13 → $17 | $12.95 | +31.27% | 1 | Jan 30, 2025 | |
| SYK Stryker | Maintains: Overweight | $427 → $435 | $386.19 | +12.64% | 15 | Jan 29, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $630 → $687 | $573.15 | +19.86% | 19 | Jan 24, 2025 | |
| JNJ Johnson & Johnson | Maintains: Equal-Weight | $166 → $152 | $165.02 | -7.89% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $24 | $16.00 | +50.00% | 4 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $145 → $153 | $120.02 | +27.48% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $10 → $8 | $8.62 | -7.19% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $88.37 | +6.37% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $118 | $90.38 | +30.56% | 16 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $106 → $98 | $92.02 | +6.50% | 17 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $110 → $117 | $104.32 | +12.15% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $80 | $71.62 | +11.70% | 15 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $105 | $92.50 | +13.51% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $40 | $34.51 | +15.91% | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $55 | $22.14 | +148.42% | 7 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $40 | $19.07 | +109.75% | 17 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $14 | $5.72 | +144.76% | 11 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.1 → $1.6 | $0.97 | +64.95% | 3 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $23.21 | +111.12% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $241 → $236 | $132.75 | +77.78% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $138.01 | -1.46% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $80.32 | -12.85% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $225.53 | +19.72% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $93.82 | - | 2 | Nov 2, 2017 |
RxSight
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $40 → $35
Current: $28.36
Upside: +23.41%
Merit Medical Systems
Feb 26, 2025
Maintains: Overweight
Price Target: $120 → $117
Current: $102.04
Upside: +14.66%
Penumbra
Feb 19, 2025
Maintains: Overweight
Price Target: $275 → $305
Current: $285.44
Upside: +6.85%
GE HealthCare Technologies
Feb 14, 2025
Maintains: Overweight
Price Target: $96 → $103
Current: $87.35
Upside: +17.92%
Inspire Medical Systems
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $198 → $195
Current: $185.59
Upside: +5.07%
Boston Scientific
Feb 6, 2025
Maintains: Overweight
Price Target: $100 → $118
Current: $103.79
Upside: +13.69%
NeuroPace
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $12.95
Upside: +31.27%
Stryker
Jan 29, 2025
Maintains: Overweight
Price Target: $427 → $435
Current: $386.19
Upside: +12.64%
Intuitive Surgical
Jan 24, 2025
Maintains: Overweight
Price Target: $630 → $687
Current: $573.15
Upside: +19.86%
Johnson & Johnson
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $165.02
Upside: -7.89%
Jan 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $16.00
Upside: +50.00%
Dec 11, 2024
Maintains: Overweight
Price Target: $145 → $153
Current: $120.02
Upside: +27.48%
Dec 11, 2024
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $8.62
Upside: -7.19%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $88.37
Upside: +6.37%
Dec 6, 2024
Maintains: Overweight
Price Target: $115 → $118
Current: $90.38
Upside: +30.56%
Nov 20, 2024
Maintains: Overweight
Price Target: $106 → $98
Current: $92.02
Upside: +6.50%
Oct 31, 2024
Maintains: Equal-Weight
Price Target: $110 → $117
Current: $104.32
Upside: +12.15%
Sep 9, 2024
Maintains: Overweight
Price Target: $90 → $80
Current: $71.62
Upside: +11.70%
Aug 22, 2024
Maintains: Overweight
Price Target: $94 → $105
Current: $92.50
Upside: +13.51%
Aug 7, 2024
Maintains: Equal-Weight
Price Target: $44 → $40
Current: $34.51
Upside: +15.91%
Aug 2, 2024
Maintains: Overweight
Price Target: $50 → $55
Current: $22.14
Upside: +148.42%
Jul 26, 2024
Maintains: Overweight
Price Target: $42 → $40
Current: $19.07
Upside: +109.75%
Apr 8, 2024
Maintains: Equal-Weight
Price Target: $17 → $14
Current: $5.72
Upside: +144.76%
Mar 22, 2024
Maintains: Equal-Weight
Price Target: $2.1 → $1.6
Current: $0.97
Upside: +64.95%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $23.21
Upside: +111.12%
Aug 4, 2023
Maintains: Equal-Weight
Price Target: $241 → $236
Current: $132.75
Upside: +77.78%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $138.01
Upside: -1.46%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $80.32
Upside: -12.85%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $225.53
Upside: +19.72%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $93.82
Upside: -